8-K/A filed September 27, 2024, 7:59 PM ET ticker CRBU CIK 0001619856

leadership confidence high sentiment neutral materiality 0.50

Caribou Biosciences appoints Ryan Fischesser interim CFO and grants 25,000 RSUs

Caribou Biosciences, Inc.

Ryan Fischesser designated interim principal financial officer and accounting officer effective Sept 27, 2024, following Jason O'Byrne's resignation.
Fischesser to receive 25,000 RSUs on Nov 20, 2024, vesting fully on Nov 20, 2025, subject to continued employment.
The original 8-K filed Sept 3, 2024 reported O'Byrne's resignation; this amendment supplements compensatory terms.
Fischesser previously served as VP of Finance and Controller.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Ryan Fischesser

Interim Principal Financial Officer and Interim Principal Accounting Officer

CRBU · Caribou Biosciences, Inc.

Effective: 2024-09-27
Filed: September 27, 2024, 7:59 PM ET

On September 23, 2024, Caribou Biosciences, Inc. (the “Company”) designated Ryan Fischesser, the Company’s current Vice President of Finance and Controller, as the Company’s interim principal financial officer and interim principal accounting officer, effective as of 5:00 p.m. Pacific time on September 27, 2024.

Departed

Jason O'Byrne

Chief Financial Officer

CRBU · Caribou Biosciences, Inc.

Effective: 2024-09-27
Filed: September 27, 2024, 7:59 PM ET

Mr. O’Byrne serves as the Company’s principal financial officer and principal accounting officer through September 27, 2024, his final day with the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ryan Fischesser was appointed as Interim Principal Financial Officer and Interim Principal Accounting Officer at Caribou Biosciences, Inc..

Action: designated
Role: Interim Principal Financial Officer and Interim Principal Accounting Officer

Exact text from the filing

On September 23, 2024, Caribou Biosciences, Inc. (the “Company”) designated Ryan Fischesser, the Company’s current Vice President of Finance and Controller, as the Company’s interim principal financial officer and interim principal accounting officer, effective as of 5:00 p.m. Pacific time on September 27, 2024.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jason O'Byrne resigned as Chief Financial Officer at Caribou Biosciences, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

Mr. O’Byrne serves as the Company’s principal financial officer and principal accounting officer through September 27, 2024, his final day with the Company.

View on SEC.gov

Caribou Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001619856-24-000074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.